A Study to Evaluate Safety and Tolerability of a Recombinant Herpes Zoster Vaccine

NCT05750017 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

66

Enrollment

OTHER

Sponsor class

Conditions

Herpes Zoster
Vaccine-Preventable Diseases

Interventions

BIOLOGICAL: Low Dose Recombinant Herpes Zoster Vaccine (LZ901)
BIOLOGICAL: High Dose Recombinant Herpes Zoster Vaccine (LZ901)
DRUG: Placebo

Sponsor

Beijing Luzhu Biotechnology Co., Ltd.